Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.

Wong NA, Morris RG, McCondochie A, Bader S, Jodrell DI, Harrison DJ.

J Pathol. 2002 May;197(1):128-35.

PMID:
12081197
2.

Evolution of colorectal cancer: change of pace and change of direction.

Jass JR, Young J, Leggett BA.

J Gastroenterol Hepatol. 2002 Jan;17(1):17-26. Review.

PMID:
11987262
3.

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC.

Histopathology. 2002 Feb;40(2):127-32.

PMID:
11952856
4.

APC, signal transduction and genetic instability in colorectal cancer.

Fodde R, Smits R, Clevers H.

Nat Rev Cancer. 2001 Oct;1(1):55-67. Review.

PMID:
11900252
5.

Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, Borten MM, Stitz R, Searle J, McKeone D, Fraser L, Purdie DR, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR.

Am J Pathol. 2001 Dec;159(6):2107-16.

6.

Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.

Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T.

Cancer Res. 2001 Nov 15;61(22):8089-93.

7.

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T.

Am J Pathol. 2001 Nov;159(5):1613-7.

8.

Mechanisms of oncogenesis in colon versus rectal cancer.

Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH.

J Pathol. 2001 Sep;195(2):171-8.

PMID:
11592095
9.
10.

Mutations at the APC exon 15 in the colorectal neoplastic tissues of serial array.

Kim JC, Koo KH, Lee DH, Roh SA, Kim HC, Yu CS, Kang GH.

Int J Colorectal Dis. 2001 Apr;16(2):102-7.

PMID:
11355315
11.
12.

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.

Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG.

Cancer Res. 2000 May 1;60(9):2368-71.

13.

Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG.

Cancer Res. 2000 Jan 1;60(1):129-33.

14.

Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis.

Umetani N, Sasaki S, Masaki T, Watanabe T, Matsuda K, Muto T.

Br J Cancer. 2000 Jan;82(1):9-15.

15.

Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.

Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J, Leggett BA.

J Clin Pathol. 1999 Jun;52(6):455-60.

16.

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T.

Am J Pathol. 1999 Oct;155(4):1033-8.

17.

Colorectal cancer with and without microsatellite instability involves different genes.

Salahshor S, Kressner U, Pâhlman L, Glimelius B, Lindmark G, Lindblom A.

Genes Chromosomes Cancer. 1999 Nov;26(3):247-52.

PMID:
10502323
18.

Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer.

Miyaki M, Iijima T, Kimura J, Yasuno M, Mori T, Hayashi Y, Koike M, Shitara N, Iwama T, Kuroki T.

Cancer Res. 1999 Sep 15;59(18):4506-9.

19.

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM.

Oncogene. 1999 May 6;18(18):2883-91.

20.

Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.

Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST.

Am J Pathol. 1999 Feb;154(2):515-23.

Supplemental Content

Support Center